HSN-431

N/A

Report date: 2025/01/26 15:17:03
NME

Base Information

Drug NameHSN-431
Drug Alias NameFLT3/Src tyrosine kinase inhibitors (Purdue University/KinaRx/University of Maryland)HSN-431
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase receptor FLT3 inhibitorsTyrosine-protein kinase SRC inhibitors
TargetsTyrosine-protein kinase SRCTyrosine-protein kinase receptor FLT3
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPurdue University
China Registration ClassN/A

Develop Information

Active CompaniesKinaRx IncPurdue UniversityUniversity Of Maryland
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A